SiPhox Health: Cambridge-based startup revolutionizing personalized health diagnostics, funded with $27M seed
August 2, 2023
Meet SiPhox Health, the Cambridge-based startup revolutionizing personalized health diagnostics. Founded by Diedrik Vermeulen and funded with $27M in seed capital from investors like Alumni Ventures, Khosla Ventures, Metaplanet, Duke Capital Partners, and Intel Capital, SiPhox Health is transforming consumer services in the health industry. Our at-home test kit measures 17 blood biomarkers, assessing inflammation, hormonal health, metabolic fitness, and cardiovascular health.
We aim to bridge home testing with central labs, building next-gen diagnostics infrastructure. With 6 out of 10 Americans battling chronic diseases, SiPhox Health's mission is to pioneer Direct-to-Consumer health and wellness solutions, addressing this pressing crisis. Unlock the power of personalized health diagnostics with SiPhox Health. Trust our vision led by founder Diedrik Vermeulen and supported by esteemed investors. Take charge of your health and embark on a journey to well-being with SiPhox Health's innovative approach.